OCGN - Ocugen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCGN is currently covered by 3 analysts with an average price target of $3.87. This is a potential upside of $2.74 (242.48%) from yesterday's end of day stock price of $1.13.

Ocugen's activity chart (see below) currently has 43 price targets and 55 ratings on display. The stock rating distribution of OCGN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.48% with an average time for these price targets to be met of 45 days.

Highest price target for OCGN is $7, Lowest price target is $7, average price target is $5.33.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 12-May-2025. First documented stock forecast 20-Jun-2018.

Currently out of the existing stock ratings of OCGN, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$5.87 (519.47%)

$8

1 months 2 days ago
(12-May-2025)

2/9 (22.22%)

$6.3 (900.00%)

92

Buy

$7

$5.87 (519.47%)

$7

1 months 2 days ago
(12-May-2025)

0/9 (0%)

$6.3 (900.00%)

Buy

$2

$0.87 (76.99%)

$4.5

1 years 9 months 14 days ago
(31-Aug-2023)

0/2 (0%)

$1.57 (365.12%)

$4.5

2 years 3 months 13 days ago
(01-Mar-2023)

2/3 (66.67%)

$-2.19 (-32.74%)

108

Buy

$3

$1.87 (165.49%)

2 years 3 months 13 days ago
(01-Mar-2023)

0/1 (0%)

$2 (200.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCGN (Ocugen) average time for price targets to be met?

On average it took 45 days on average for the stock forecasts to be realized with a an average price target met ratio 39.48

Which analyst has the current highest performing score on OCGN (Ocugen) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on OCGN (Ocugen) with a proven track record?

JENNIFER KIM

Which analyst has the most public recommendations on OCGN (Ocugen)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 3 price targets and 5 ratings on OCGN

Which analyst is the currently most bullish on OCGN (Ocugen)?

Daniil Gataulin with highest potential upside - $5.87

Which analyst is the currently most reserved on OCGN (Ocugen)?

Kristen Kluska with lowest potential downside - -$0

Ocugen in the News

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026 Anticipate initiating OCU410ST Phase 2/3 pivotal confirmatory clinical trial for Stargardt disease mid- 2025 MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen...

Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results

MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s first quarter 2025 financial results and provide a business update at 8:30 a.m....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?